SK
Shardendu Kumar Bhardwaj
About Shardendu Kumar Bhardwaj
Data last updated:
Shardendu Kumar Bhardwaj is a Director at Astrazest Pharma Private Limited (since 2021) and Additional Director at Kenotas Labs Private Limited (since 2020). The companies operate in Chemicals and Food And Beverages. The largest current company by reported revenue is Astrazest Pharma Private Limited at ₹38,160 (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Jan 2021 | 2021 | ₹38,160 (FY 2023) | Active | |
| Additional Director | 12 Feb 2020 | 2017 | Active |
Board colleagues of Shardendu Kumar Bhardwaj
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vagish Mani Tripathi | 08696986 | Astrazest Pharma Private Limited , Kenotas Labs Private Limited | Director |
| Kiran Sharma | 07731097 | Kenotas Labs Private Limited | Director |
| Uttam Sharma | 07729843 | Kenotas Labs Private Limited | Managing Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shardendu Kumar Bhardwaj
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shardendu Kumar Bhardwaj
Shardendu Kumar Bhardwaj currently holds 2 directorships: Astrazest Pharma Private Limited (Director, since 11 Jan 2021, revenue ₹38,160 (FY 2023)); Kenotas Labs Private Limited (Additional Director, since 12 Feb 2020).
Shardendu Kumar Bhardwaj was first appointed on 12 Feb 2020 as Additional Director at Kenotas Labs Private Limited. The most recent appointment on record is 11 Jan 2021 at Astrazest Pharma Private Limited.
The current boards of Shardendu Kumar Bhardwaj's companies include Vagish Mani Tripathi (Astrazest Pharma Private Limited), Kiran Sharma (Kenotas Labs Private Limited), Uttam Sharma (Kenotas Labs Private Limited).